European Journal of Dermatology
MENUTopical tretinoin in the treatment of vulvar lichen sclerosus: an advisable option?Topical tretinoin in the treatment of vulvar lichen sclerosus Volume 25, numéro 5, September-October 2015
Auteurs
Dipartimento di Scienze Mediche,
Sezione di Dermatologia e Malattie Infettive
Università degli Studi di Ferrara,
Via Savonarola 9, 44121 Ferrara, Italy
Sezione di Dermatologia e Malattie Infettive
Università degli Studi di Ferrara,
Via Savonarola 9, 44121 Ferrara, Italy
* Reprints
- Mots-clés : vulvar lichen sclerosus, topical tretinoin, active treatment, efficacy, safety
- DOI : 10.1684/ejd.2015.2595
- Page(s) : 404-9
- Année de parution : 2015
Vulvar lichen sclerosus (VLS) is an inflammatory disease affecting the ano-genital areas. Immunological alterations and chronic inflammatory mechanisms seem to be crucial aetiopathogenetic factors [1-4].The ultra-potent corticosteroid clobetasol propionate (CP) represents the recommended first-line treatment for VLS [5-7]. Recent comparative studies have shown that mometasone furoate 0.1% (MMF) results as efficacious and is as well tolerated as CP for the treatment of VLS, both in the active phase [...]